WINSTON J CHURCHILL Insider Trading $REPH Recro Pharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for WINSTON J CHURCHILL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of WINSTON J CHURCHILL. WINSTON J CHURCHILL is Director in GRIFFIN INDUSTRIAL REALTY, INC. ($GRIF) and Director in AMKOR TECHNOLOGY, INC. ($AMKR) and Director in INNOVATIVE SOLUTIONS & SUPPORT INC ($ISSC) and Director in Recro Pharma, Inc. ($REPH) and Director in Baudax Bio, Inc. ($BXRX).
WINSTON J CHURCHILL in Recro Pharma, Inc.
Trading Symbol: REPHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of WINSTON J CHURCHILL: Director
Holdings: 77,982 shares
Current Value: $627,755
Latest Transaction: Apr 22 2021
$REPH Market Capitalization: $98.40M
$REPH Previous Close: $8.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of WINSTON J CHURCHILL in Recro Pharma, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMKR, BXRX, GRIF, ISSC, REPH
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 22 2021 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Option Exercise | A | 1.71 | 38,012 | 65,001 | 38,012 | |
Apr 22 2021 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Grant | A | 0.00 | 26,923 | 0 | 77,982 | 51.1 K to 78 K (+52.73 %) |
May 11 2020 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Option Exercise | A | 8.37 | 12,405 | 103,830 | 12,405 | |
May 11 2020 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Grant | A | 0.00 | 8,363 | 0 | 51,059 | 42.7 K to 51.1 K (+19.59 %) |
Dec 09 2019 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Grant | A | 0.00 | 15,284 | 0 | 42,696 | 27.4 K to 42.7 K (+55.76 %) |
May 14 2018 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Option Exercise | M | 0.00 | 13,274 | 0 | 0 | |
May 14 2018 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Buy | M | 0.00 | 13,274 | 0 | 19,457 | 6.2 K to 19.5 K (+214.69 %) |
May 08 2018 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Option Exercise | A | 11.32 | 5,742 | 64,999 | 5,742 | |
May 08 2018 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Grant | A | 0.00 | 6,183 | 0 | 6,183 | 0 to 6.2 K |
May 16 2017 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Option Exercise | A | 0.00 | 13,274 | 0 | 13,274 | |
May 23 2016 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Sell | S | 6.45 | 5,008 | 32,326 | 778,634 | 783.6 K to 778.6 K (-0.64 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Sell | S | 6.45 | 14,992 | 96,770 | 2,330,321 | 2.3 M to 2.3 M (-0.64 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Sell | S | 6.46 | 1,252 | 8,083 | 783,642 | 784.9 K to 783.6 K (-0.16 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Sell | S | 6.46 | 3,748 | 24,197 | 2,345,313 | 2.3 M to 2.3 M (-0.16 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Sell | S | 9.00 | 150 | 1,350 | 784,894 | 785 K to 784.9 K (-0.02 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Sell | S | 9.00 | 450 | 4,050 | 2,349,061 | 2.3 M to 2.3 M (-0.02 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Sell | S | 9.00 | 2,250 | 20,252 | 785,044 | 787.3 K to 785 K (-0.29 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Sell | S | 9.00 | 6,737 | 60,639 | 2,349,511 | 2.4 M to 2.3 M (-0.29 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Sell | S | 9.00 | 1,553 | 13,977 | 787,294 | 788.8 K to 787.3 K (-0.20 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Sell | S | 9.00 | 4,648 | 41,832 | 2,356,248 | 2.4 M to 2.4 M (-0.20 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Sell | S | 9.01 | 691 | 6,223 | 788,847 | 789.5 K to 788.8 K (-0.09 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Sell | S | 9.01 | 2,068 | 18,624 | 2,360,896 | 2.4 M to 2.4 M (-0.09 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Sell | S | 9.00 | 3,702 | 33,321 | 789,538 | 793.2 K to 789.5 K (-0.47 %) |
May 23 2016 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Sell | S | 9.00 | 11,082 | 99,748 | 2,362,964 | 2.4 M to 2.4 M (-0.47 %) |
Dec 18 2015 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Option Exercise | A | 8.41 | 10,000 | 84,100 | 10,000 |
Page: 1